StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · HCAT·Healthcare

Health Catalyst, Inc. Stock Analysis & AI Score

Market Open
$1.79
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
44
ST Score
44.3/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HCAT
44.3out of 100
Grade C+

Health Catalyst, Inc. (HCAT) holds an ST Score of 44.3 out of 100 (C+), with its strongest factor being Sentiment (A+) and its weakest Profitability (D-). Analysts rate HCAT Buy across 22 ratings with a $1.77 average price target (-0.0% vs the current $1.79).

Strongest
SentimentA+
Weakest
ProfitabilityD-
All factor grades
  • SentimentA+
  • MomentumB-
  • ValuationC+
  • Financial StrengthC
  • ForecastC-
  • GrowthD+
  • ProfitabilityD-
  • Piotroski5/9
Score methodology
Press Releases

Contact

HCAT stock: frequently asked questions

What is HCAT's ST Score?

Health Catalyst, Inc. (HCAT) has an ST Score of 44.3 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HCAT a buy, sell, or hold?

Wall Street's consensus rating on HCAT is Buy based on 22 analyst ratings. Our own ST Score grades it C+ (44.3/100). This is data, not investment advice — always do your own research.

What is HCAT's valuation grade?

Health Catalyst, Inc. (HCAT) earns a valuation grade of C+, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HCAT's growth grade?

Health Catalyst, Inc. (HCAT) earns a growth grade of D+, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HCAT's profitability grade?

Health Catalyst, Inc. (HCAT) earns a profitability grade of D-, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HCAT's financial strength grade?

Health Catalyst, Inc. (HCAT) earns a financial strength grade of C, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for HCAT?

The average analyst price target for Health Catalyst, Inc. (HCAT) is $1.77 from 22 analysts, which is -0.0% versus the recent price of $1.79.

What is HCAT's Piotroski score?

Health Catalyst, Inc. (HCAT) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.